Drill into your own data to see whether and to what degree these national inpatient trends are occuring in your own area.
HEALTH PLANS that are hoping to reduce inpatient volumes would be best served by reviewing their reimbursement and provider incentives for preventive care, say experts.
Obviously, a hospital inpatient admission typically represents the most expensive form of service or treatment, says Marc Mertz, senior manager with The Camden Group, national healthcare advisory firm based in Los Angeles.
RENAL FAILURE GROWS
According to Thomson Reuters, the fastest-growing clinical condition is renal failure, specifically acute renal failure. The reasons for this growth are not fully known, but may be due to the increased rate of diabetes and hypertension, expanded criteria for diagnosing renal failure, and coding changes.
Increasing reimbursement rates for relatively low-cost services such as preventive exams and screenings can reduce admission rates, Mertz says.
"For example, renal failure discharges, which according to [Thomson Reuters] had the highest growth rate, can be reduced by encouraging patients to have annual exams and blood work," he says. "One of the best ways to accomplish this is to provide quality incentives to primary care physicians. The alignment of patient, provider, and payer incentives can, in this case, result in higher quality care and less expense to the healthcare industry."
Another finding from Thomson Reuters shows the demand for major cardiovascular care continues to decline.
"Our prior research has shown that the prevalence of heart disease in hospital patients has increased-as expected-with the aging population," says Dr. Schutt. "However, heart disease is increasingly less likely to be the primary reason for hospitalization, most likely due to long-term population treatment for risk factors such as elevated cholesterol and high blood pressure."
Executives should drill into their own data to see whether, and to what degree, these national trends are occurring in their service areas.
"There is great variation around these types of indicators, and the national average may not reflect what is happening in any given locality," Dr. Schutt says. "Managed care executives should make decisions based on a sound understanding of the local picture."
Mertz agrees that healthcare trends and utilization rates can be highly localized depending on variations in patient populations, physicians, and the availability of services and facilities.
"It is imperative that plans understand what their service area data indicates rather than what national trends suggest," he says. "The accessibility of pertinent and accurate data will continue to be key to organizations' success."
-Tracey WalkerCommentary is independent of source data
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More